On October 2, 2019, a judge in the Federal Court of Australia ordered medical device company ObjectiVision to pay over $1 million in legal costs accrued by the University of Sydney during a contract and copyright dispute between the parties concerning a glaucoma-testing product called AccuMap and associated software.
The dispute began in 2013, when the University of Sydney alleged that “Objectivision was infringing its patented technology and that its termination of Objectivision’s exclusive rights [to AccuMap] was valid.”
